View in EDS HTML Full Text PDF Full Text

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.

Saved in:
Bibliographic Details
Title: Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
Authors: Fortuno C; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lee K; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Olivier M; International Agency for Research on Cancer, Lyon, France., Pesaran T; Ambry Genetics, Aliso Viejo, California, USA., Mai PL; Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., de Andrade KC; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Attardi LD; Departments of Radiation-Oncology and Genetics, Stanford University, Stanford, California, USA., Crowley S; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Evans DG; University of Manchester, Manchester, UK., Feng BJ; University of Utah, Salt Lake City, Utah, USA., Foreman AKM; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Frone MN; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Huether R; Tempus, Chicago, Illinois, USA., James PA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., McGoldrick K; Ambry Genetics, Aliso Viejo, California, USA., Mester J; GeneDx, Gaithersburg, Maryland, USA., Seifert BA; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Slavin TP; City of Hope, Duarte, California, USA., Witkowski L; Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Maryland, USA., Zhang L; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Plon SE; Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA., Spurdle AB; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Corporate Authors: ClinGen TP53 Variant Curation Expert Panel
Source: Human mutation [Hum Mutat] 2021 Mar; Vol. 42 (3), pp. 223-236. Date of Electronic Publication: 2020 Dec 25.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33300245
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fortuno+C%22">Fortuno C</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+K%22">Lee K</searchLink>; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Olivier+M%22">Olivier M</searchLink>; International Agency for Research on Cancer, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Pesaran+T%22">Pesaran T</searchLink>; Ambry Genetics, Aliso Viejo, California, USA.<br /><searchLink fieldCode="AU" term="%22Mai+PL%22">Mai PL</searchLink>; Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22de+Andrade+KC%22">de Andrade KC</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Attardi+LD%22">Attardi LD</searchLink>; Departments of Radiation-Oncology and Genetics, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Crowley+S%22">Crowley S</searchLink>; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Evans+DG%22">Evans DG</searchLink>; University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Feng+BJ%22">Feng BJ</searchLink>; University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Foreman+AKM%22">Foreman AKM</searchLink>; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Frone+MN%22">Frone MN</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Huether+R%22">Huether R</searchLink>; Tempus, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22James+PA%22">James PA</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22McGoldrick+K%22">McGoldrick K</searchLink>; Ambry Genetics, Aliso Viejo, California, USA.<br /><searchLink fieldCode="AU" term="%22Mester+J%22">Mester J</searchLink>; GeneDx, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Seifert+BA%22">Seifert BA</searchLink>; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Slavin+TP%22">Slavin TP</searchLink>; City of Hope, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Witkowski+L%22">Witkowski L</searchLink>; Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Plon+SE%22">Plon SE</searchLink>; Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Spurdle+AB%22">Spurdle AB</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Savage+SA%22">Savage SA</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ClinGen+TP53+Variant+Curation+Expert+Panel%22">ClinGen TP53 Variant Curation Expert Panel</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229215429%22">Human mutation</searchLink> [Hum Mutat] 2021 Mar; Vol. 42 (3), pp. 223-236. <i>Date of Electronic Publication: </i>2020 Dec 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9215429 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-1004 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210597794%22">10597794 </searchLink><i>NLM ISO Abbreviation: </i>Hum Mutat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33300245
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/humu.24152
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 223
    Titles:
      – TitleFull: Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fortuno C
      – PersonEntity:
          Name:
            NameFull: Lee K
      – PersonEntity:
          Name:
            NameFull: Olivier M
      – PersonEntity:
          Name:
            NameFull: Pesaran T
      – PersonEntity:
          Name:
            NameFull: Mai PL
      – PersonEntity:
          Name:
            NameFull: de Andrade KC
      – PersonEntity:
          Name:
            NameFull: Attardi LD
      – PersonEntity:
          Name:
            NameFull: Crowley S
      – PersonEntity:
          Name:
            NameFull: Evans DG
      – PersonEntity:
          Name:
            NameFull: Feng BJ
      – PersonEntity:
          Name:
            NameFull: Foreman AKM
      – PersonEntity:
          Name:
            NameFull: Frone MN
      – PersonEntity:
          Name:
            NameFull: Huether R
      – PersonEntity:
          Name:
            NameFull: James PA
      – PersonEntity:
          Name:
            NameFull: McGoldrick K
      – PersonEntity:
          Name:
            NameFull: Mester J
      – PersonEntity:
          Name:
            NameFull: Seifert BA
      – PersonEntity:
          Name:
            NameFull: Slavin TP
      – PersonEntity:
          Name:
            NameFull: Witkowski L
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Plon SE
      – PersonEntity:
          Name:
            NameFull: Spurdle AB
      – PersonEntity:
          Name:
            NameFull: Savage SA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2021 Mar
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1098-1004
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Human mutation
              Type: main
ResultId 1